An observational study in Pseudotumor Cerebri, sponsored by University of South Florida. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by University of South Florida · Observational
The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with pseudotumor cerebri.
The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with pseudotumor cerebri.
Flow may be limited due to slit ventricles
52 studies on the registry are indexed under Pseudotumor Cerebri; 21 are open to participants now.
This study's enrollment of 12 is below the median of 62 across 16 observational studies indexed under Pseudotumor Cerebri.
Browse Pseudotumor Cerebri studies →University of South Florida is the lead sponsor of 333 studies on the registry; 63 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population will consist of asymptomatic PTC research subjects who have a VP shunt with a single ventricular catheter implanted for PTC and are visiting for routine care.
Exclusion Criteria:
Participants will be administered the ShuntCheck diagnostic test.
Diagnostic Test: ShuntCheck
The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.
Specificity of ShuntCheck test
Time frame: 15 minutes
Negative Predictive Value of ShuntCheck test
Time frame: 15 minutes
Specificity of performing ShuntCheck test twice
Time frame: 60 minutes
Negative Predictive Value of performing ShuntCheck test twice
Time frame: 60 minutes
Plan to share: No — At present there is no plan to share any individual participant data.
No publications or documents are linked to this record.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of South Florida